24 research outputs found

    Turning points in the transition to parenthood: Variability of father involvement over time

    Get PDF
    "Although fathers' involvement in care work has increased, the transition to parenthood still implies a gendered division of labour. In order to gain more knowledge of this ambivalence, we focus on the variability of father involvement at this transition. Based on an Austrian qualitative longitudinal study with couples experiencing the transition to first-time parenthood, we examined how fathers' affective, cognitive and behavioural involvement varies across the transition process. Changes in fathers' involvement culminated at particular points in time, conceptualised as turning points. Results show that the transition to fatherhood is characterised by a variety of prepregnancy, prenatal and postnatal turning points at which father involvement undergoes crucial transformations. Father involvement varies not only between fathers, but also within individual transitions. The study indicates that turning points contribute to the dynamics and fluidity of the transition process." (author's abstract)"Obwohl die väterliche Beteiligung an der Betreuungsarbeit im Steigen begriffen ist, ist der Übergang zur Elternschaft nach wie vor mit einer geschlechtsspezifischen und ungleichen Arbeitsteilung verbunden. Um diese Ambivalenz zu verstehen, konzentrieren wir uns auf die Variabilität väterlicher Beteiligung bei diesem Übergang. Anhand einer österreichischen qualitativen Längsschnittstudie mit Paaren, die das erste Mal Eltern werden, wurde untersucht, wie sich die affektive, kognitive und verhaltensmäßige Beteiligung in diesem Transitionsprozess verändert. Die Ergebnisse zeigen, dass der Übergang zur Elternschaft sich durch zahlreiche Wendepunkte (turning points) auszeichnet, an denen väterliche Beteiligung eine wesentliche Änderung erfährt. Diese Wendepunkte können vor und während der Schwangerschaft sowie nach der Geburt auftreten. Die Beteiligung variiert nicht nur zwischen Vätern, sondern auch innerhalb individueller Übergänge. Wendepunkte implizieren einen Wechsel in der Arbeitsteilung zwischen Müttern und Vätern und tragen zur Dynamik und Fluidität des Transitionsprozesses bei." (Autorenreferat

    Correlation between Macular Neovascularization (MNV) Type and Druse Type in Neovascular Age-Related Macular Degeneration (AMD) Based on the CONAN Classification

    Full text link
    To investigate associations and predictive factors between macular neovascularization (MNV) lesion variants and drusen types in patients with treatment-naĂŻve neovascular age-related macular degeneration (AMD). Methods: Multimodal imaging was retrospectively reviewed for druse type (soft drusen, subretinal drusenoid deposits (SDDs) or mixed) and MNV type (MNV 1, MNV 2, MNV 1/2 or MNV 3). The Consensus on Neovascular AMD Nomenclature (CONAN) classification was used for characterizing MNV at baseline. Results: One eye of each eligible patient was included (n = 191). Patients with predominant SDDs had an increased adjusted odds ratio (aOR) for MNV 2 (23.4453, p = 0.0025) and any type of MNV 3 (8.7374, p < 0.0001). Patients with MNV 1/2 had an aOR for predominant SDDs (0.3284, p = 0.0084). Patients with MNV1 showed an aOR for SDDs (0.0357, p < 0.0001). Eyes with SDDs only without other drusen types showed an aOR for MNV 2 (9.2945, p < 0.0001). Conclusions: SDDs represent a common phenotypic characteristic in AMD eyes with treatment-naĂŻve MNV. The aOR for eyes with predominant SDDs to develop MNV 2 and MNV 3 was much higher, possibly due to their location in the subretinal space. The predominant druse type may help to predict which type of MNV will develop during the course of AMD

    Bounce Rock—A shergottite-like basalt encountered at Meridiani Planum, Mars

    Get PDF
    The Opportunity rover of the Mars Exploration Rover mission encountered an isolated rock fragment with textural, mineralogical, and chemical properties similar to basaltic shergottites. This finding was confirmed by all rover instruments, and a comprehensive study of these results is reported here. Spectra from the miniature thermal emission spectrometer and the Panoramic Camera reveal a pyroxene-rich mineralogy, which is also evident in M&ouml;ssbauer spectra and in normative mineralogy derived from bulk chemistry measured by the alpha particle X-ray spectrometer. The correspondence of Bounce Rock&rsquo;s chemical composition with the composition of certain basaltic shergottites, especially Elephant Moraine (EET) 79001 lithology B and Queen Alexandra Range (QUE) 94201, is very close, with only Cl, Fe, and Ti exhibiting deviations. Chemical analyses further demonstrate characteristics typical of Mars such as the Fe &frasl;Mn ratio and P concentrations. Possible shock features support the idea that Bounce Rock was ejected from an impact crater, most likely in the Meridiani Planum region. Bopolu crater, 19.3 km in diameter, located 75 km to the southwest could be the source crater. To date, no other rocks of this composition have been encountered by any of the rovers on Mars. The finding of Bounce Rock by the Opportunity rover provides further direct evidence for an origin of basaltic shergottite meteorites from Mars.Additional co-authors: Thanasis ECONOMOU, Steven P. GOREVAN, Brian C. HAHN, Göstar KLINGELHÖFER, Timothy J. McCOY, Harry Y. McSWEEN Jr, Douglas W. MING, Richard V. MORRIS, Daniel S. RODIONOV, Steven W. SQUYRES, Heinrich WÄNKE, Shawn P. WRIGHT, Michael B. WYATT, Albert S. YE

    The Bandim TBscore – reliability, further development, and evaluation of potential uses

    Get PDF
    Background: The tuberculosis (TB) case detection rate has stagnated at 60% due to disorganized case finding and insensitivity of sputum smear microscopy. Of the identified TB cases, 4% die while being treated, monitored with tools that insufficiently predict failure/mortality. Objective: To explore the TBscore, a recently proposed clinical severity measure for pulmonary TB (PTB) patients, and to refine, validate, and investigate its place in case finding. Design: The TBscore's inter-observer agreement was assessed and compared to the Karnofsky Performance Score (KPS) (paper I). The TBscore's variables underlying constructs were assessed, sorting out unrelated items, proposing a more easily assessable TBscoreII, which was validated internally and externally (paper II). Finally, TBscore and TBscoreII's place in PTB-screening was examined in paper III. Results: The inter-observer variability when grading PTB patients into severity classes was moderate for both TBscore (κ W=0.52, 95% CI 0.46–0.56) and KPS (κ W=0.49, 95% CI 0.33–0.65). KPS was influenced by HIV status, whereas TBscore was unaffected by it. In paper II, proposed TBscoreII was validated internally, in Guinea-Bissau, and externally, in Ethiopia. In both settings, a failure to bring down the score by ≥25% from baseline to 2 months of treatment predicted subsequent failure (p=0.007). Finally, in paper III, TBscore and TBscoreII were assessed in health-care-seeking adults and found to be higher in PTB-diagnosed patients, 4.9 (95% CI 4.6–5.2) and 3.9 (95% CI 3.8–4.0), respectively, versus patients not diagnosed with PTB, 3.0 (95% CI 2.7–3.2) and 2.4 (95% CI 2.3–2.5), respectively. Had we referred only patients with cough >2 weeks to sputum smear, we would have missed 32.1% of the smear confirmed cases in our cohort. A TBscoreII>=2 missed 8.6%. Conclusions: TBscore and TBscoreII are useful monitoring tools for PTB patients on treatment, as they could fill the void which currently exists in risk grading of patients. They may also have a role in PTB screening; however, this requires our findings to be repeated elsewhere

    Regulatory Architecture of the Neuronal Cacng2/TarpÎł2 Gene Promoter: Multiple Repressive Domains, a Polymorphic Regulatory Short Tandem Repeat, and Bidirectional Organization with Co-regulated lncRNAs

    Get PDF
    CACNG2 (TARPγ2, Stargazin) is a multi-functional regulator of excitatory neurotransmission and has been implicated in the pathological processes of several brain diseases. Cacng2 function is dependent upon expression level, but currently, little is known about the molecular mechanisms that control expression of this gene. To address this deficit and investigate disease-related gene variants, we have cloned and characterized the rat Cacng2 promoter and have defined three major features: (i) multiple repressive domains that include an array of RE-1 silencing transcription factor (REST) elements, and a calcium regulatory element-binding factor (CaRF) element, (ii) a (poly-GA) short tandem repeat (STR), and (iii) bidirectional organization with expressed lncRNAs. Functional activity of the promoter was demonstrated in transfected neuronal cell lines (HT22 and PC12), but although selective removal of REST and CaRF domains was shown to enhance promoter-driven transcription, the enhanced Cacng2 promoter constructs were still about fivefold weaker than a comparable rat Synapsin-1 promoter sequence. Direct evidence of REST activity at the Cacng2 promoter was obtained through co-transfection with an established dominant-negative REST (DNR) construct. Investigation of the GA-repeat STR revealed polymorphism across both animal strains and species, and size variation was also observed in absence epilepsy disease model cohorts (Genetic Absence Epilepsy Rats, Strasbourg [GAERS] and non-epileptic control [NEC] rats). These data provide evidence of a genotype (STR)-phenotype correlation that may be unique with respect to proximal gene regulatory sequence in the demonstrated absence of other promoter, or 3′ UTR variants in GAERS rats. However, although transcriptional regulatory activity of the STR was demonstrated in further transfection studies, we did not find a GAERS vs. NEC difference, indicating that this specific STR length variation may only be relevant in the context of other (Cacna1h and Kcnk9) gene variants in this disease model. Additional studies revealed further (bidirectional) complexity at the Cacng2 promoter, and we identified novel, co-regulated, antisense rat lncRNAs that are paired with Cacng2 mRNA. These studies have provided novel insights into the organization of a synaptic protein gene promoter, describing multiple repressive and modulatory domains that can mediate diverse regulatory inputs

    A Conclusive Concept for Three-Dimensional Imaging Based on Efficient Steering and Focusing of an Ultrasonic 2D-Array

    No full text
    Abstract. A 16-by-16 element array is operated at a center frequency of 2.25 MHz using a 256-channel transmitter system. Reception is performed with a subset of elements of the array or with a separate single element probe. The beam fields generated in water have been simulated and compared to experiments with excellent agreement. 3D imaging of defects inside components has been addressed only by electronic steering and focusing to various depths of the inspected component. Work has also been done using an 8-by-8 element array

    Correlation between Macular Neovascularization (MNV) Type and Druse Type in Neovascular Age-Related Macular Degeneration (AMD) Based on the CONAN Classification

    No full text
    To investigate associations and predictive factors between macular neovascularization (MNV) lesion variants and drusen types in patients with treatment-na&iuml;ve neovascular age-related macular degeneration (AMD). Methods: Multimodal imaging was retrospectively reviewed for druse type (soft drusen, subretinal drusenoid deposits (SDDs) or mixed) and MNV type (MNV 1, MNV 2, MNV 1/2 or MNV 3). The Consensus on Neovascular AMD Nomenclature (CONAN) classification was used for characterizing MNV at baseline. Results: One eye of each eligible patient was included (n = 191). Patients with predominant SDDs had an increased adjusted odds ratio (aOR) for MNV 2 (23.4453, p = 0.0025) and any type of MNV 3 (8.7374, p &lt; 0.0001). Patients with MNV 1/2 had an aOR for predominant SDDs (0.3284, p = 0.0084). Patients with MNV1 showed an aOR for SDDs (0.0357, p &lt; 0.0001). Eyes with SDDs only without other drusen types showed an aOR for MNV 2 (9.2945, p &lt; 0.0001). Conclusions: SDDs represent a common phenotypic characteristic in AMD eyes with treatment-na&iuml;ve MNV. The aOR for eyes with predominant SDDs to develop MNV 2 and MNV 3 was much higher, possibly due to their location in the subretinal space. The predominant druse type may help to predict which type of MNV will develop during the course of AMD
    corecore